From: The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
 | Pre-transplant | 1st month | 3rd month | 6th month | 12th month | 24th month | 36th month | 48th month | |
---|---|---|---|---|---|---|---|---|---|
Variables | CsA (n) | 60 | 60 | 60 | 60 | 60 | 60 | 56 | 55 |
Tac (n) | 68 | 68 | 68 | 68 | 68 | 68 | 60 | 56 | |
Systolic BP (mmHg) | CsA | 127.4 ± 23.4 | 127.7 ± 13.6 | 127.0 ± 13.0 | 128.5 ± 15.6 | 127.7 ± 15.1 | 124.6 ± 13.8 | 125.0 ± 14.0 | 128.8 ± 18.8 |
Tac | 122.2 ± 16.6 | 126.6 ± 14.5 | 123.9 ± 13.9 | 123.2 ± 15.2 | 126.4 ± 16.7 | 124.1 ± 18.3 | 125.9 ± 20.7 | 127.2 ± 17.4 | |
Diastolic BP (mmHg) | CsA | 79.1 ± 11.6 | 79.5 ± 8.3 | 79.8 ± 8.7 | 79.8 ± 8.9 | 78.0 ± 7.9 | 77.6 ± 9.4 | 75.1 ± 11.3* | 75.8 ± 13.5 |
Tac | 76.1 ± 10.0 | 80.1 ± 9.6* | 78.5 ± 8.6 | 78.8 ± 9.2 | 77.3 ± 9.5 | 75.1 ± 10.9 | 75.3 ± 13.5 | 76.2 ± 12.2 | |
Hemoglobin (g/dL) | CsA | 11.59 ± 1.88 | 12.0 ± 1.80 | 12.82 ± 2.44** | 12.73 ± 2.15** | 12.97 ± 1.95** | 12.77 ± 1.76** | 12.82 ± 1.76** | 12.54 ± 1.79* |
Tac | 11.16 ± 1.89 | 11.5 ± 1.51 | 12.91 ± 1.88** | 12.67 ± 1.97** | 12.96 ± 1.96** | 13.11 ± 1.57** | 13.22 ± 1.61** | 13.2 ± 1.51** | |
Albumin (g/dL) | CsA | 3.47 ± 0.63 | 3.44 ± 0.57 | 3.80 ± 0.48** | 3.92 ± 0.43** | 4.06 ± 0.31** | 4.11 ± 0.39** | 4.10 ± 0.34** | 4.14 ± 0.31** |
Tac | 3.52 ± 0.64 | 3.76 ± 0.44* | 4.07 ± 0.58** | 4.06 ± 0.55** | 4.15 ± 0.34** | 4.20 ± 0.39** | 4.21 ± 0.35** | 4.22 ± 0.38** | |
Creatinine (mg/dL) | CsA | 8.83 ± 3.2 | 1.33 ± 0.5 | 1.27 ± 0.4 | 1.41 ± 0.5 | 1.27 ± 0.4 | 1.37 ± 0.7 | 1.44 ± 0.9 | 1.36 ± 0.5 |
Tac | 8.83 ± 2.5 | 1.32 ± 0.8 | 1.28 ± 0.5 | 1.42 ± 0.5 | 1.41 ± 0.6 | 1.39 ± 0.6 | 1.41 ± 0.6 | 1.52 ± 0.7 | |
eGFR (mL/min/1.73 m2) | CsA | 7.13 ± 3.7 | 63.8 ± 26.1 | 66.0 ± 24.3 | 58.9 ± 21.3 | 64.9 ± 19.7 | 62.5 ± 21.0 | 60.2 ± 23.5 | 60.8 ± 21.1 |
Tac | 7.29 ± 3.0 | 69.1 ± 27.6 | 68.5 ± 25.2 | 60.6 ± 24.0q | 63.9 ± 26.2 | 63.6 ± 26.0 | 63.4 ± 26.8 | 59.0 ± 22.9qq |